Yan Peng

9PUBLICATIONS
56CO-AUTHORS
Molecular targetsPredictive and prognostic markersOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 30, 2025
The Molecular Landscape and Utility of Multiomic Analyses in Triple-Negative Breast Cancer: Further Subtyping and Exploring Novel Biomarkers and Therapeutic Targets.

Conan Juan, Yan Peng

|Jul 14, 2025
A Four Amino Acid Intracellular Motif of VISTA Blocks Growth Receptor Signaling in Cancer Cells to Induce Tumor Suppression.

Yan Zhao, Tina Andoh, Fatima Charles

|Feb 13, 2025
Unique Molecular Alteration of Lobular Breast Cancer: Association with Pathological Classification, Tumor Biology and Behavior, and Clinical Management.

Huina Zhang, Yan Peng

|Jan 08, 2024
AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2+ Breast Cancer.

Mauricio Marquez-Palencia, Luis Reza Herrera, Pravat Kumar Parida

|Jan 08, 2023
Current Biological, Pathological and Clinical Landscape of HER2-Low Breast Cancer.

Huina Zhang, Yan Peng

|Dec 24, 2021
The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer.

Lin He, Neda Wick, Sharon Koorse Germans

Pageof 2

Frequent Collaborators

2 joint publications

Yang Zhang

1 joint publications

Laura E Herring

1 joint publications

Jason W Locasale

1 joint publications

Giada Zurlo